1. Home
  2. BHR vs LUNG Comparison

BHR vs LUNG Comparison

Compare BHR & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHR
  • LUNG
  • Stock Information
  • Founded
  • BHR 2013
  • LUNG 1995
  • Country
  • BHR United States
  • LUNG United States
  • Employees
  • BHR N/A
  • LUNG N/A
  • Industry
  • BHR Real Estate Investment Trusts
  • LUNG Industrial Specialties
  • Sector
  • BHR Real Estate
  • LUNG Health Care
  • Exchange
  • BHR Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • BHR 222.2M
  • LUNG 251.5M
  • IPO Year
  • BHR N/A
  • LUNG 2020
  • Fundamental
  • Price
  • BHR $3.23
  • LUNG $6.06
  • Analyst Decision
  • BHR Hold
  • LUNG Buy
  • Analyst Count
  • BHR 1
  • LUNG 6
  • Target Price
  • BHR $2.50
  • LUNG $11.92
  • AVG Volume (30 Days)
  • BHR 165.2K
  • LUNG 214.9K
  • Earning Date
  • BHR 11-06-2024
  • LUNG 10-30-2024
  • Dividend Yield
  • BHR 5.78%
  • LUNG N/A
  • EPS Growth
  • BHR N/A
  • LUNG N/A
  • EPS
  • BHR N/A
  • LUNG N/A
  • Revenue
  • BHR $732,339,000.00
  • LUNG $79,302,000.00
  • Revenue This Year
  • BHR N/A
  • LUNG $22.26
  • Revenue Next Year
  • BHR N/A
  • LUNG $18.72
  • P/E Ratio
  • BHR N/A
  • LUNG N/A
  • Revenue Growth
  • BHR N/A
  • LUNG 22.34
  • 52 Week Low
  • BHR $1.79
  • LUNG $5.46
  • 52 Week High
  • BHR $3.95
  • LUNG $14.84
  • Technical
  • Relative Strength Index (RSI)
  • BHR 42.34
  • LUNG 44.10
  • Support Level
  • BHR $3.35
  • LUNG $6.07
  • Resistance Level
  • BHR $3.54
  • LUNG $6.32
  • Average True Range (ATR)
  • BHR 0.15
  • LUNG 0.39
  • MACD
  • BHR -0.04
  • LUNG -0.02
  • Stochastic Oscillator
  • BHR 6.36
  • LUNG 21.03

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and Renaissance, among others.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: